Meningococcal vaccination in pregnancy

Hum Vaccin Immunother. 2018 May 4;14(5):1188-1196. doi: 10.1080/21645515.2018.1445447. Epub 2018 Mar 21.


Invasive meningococcal disease causes meningitis and septicemia worldwide with highest rates of disease occurring in children <2 years of age, and in particular young infants. Vaccination during pregnancy has been a successful strategy for prevention of other infections in young infants, most notably tetanus, pertussis and influenza. However, few studies of meningococcal vaccines in pregnancy have been undertaken, and none include the most commonly used current vaccines to prevent disease by capsular groups A, B, C, W and Y. The limited data suggest that the older polysaccharide vaccines are immunogenic, but the impact on prevention of infant disease has not been measured. Further studies of MenB protein vaccines and MenA protein-polysaccharide conjugate vaccines in particular are needed if vaccination in pregnancy is to be utilized as an approach to prevention of meningococcal disease in young infants.

Keywords: Neisseria meningitidis; antenatal; immunization; infant; meningitis; newborn; septicemia; vaccines.

Publication types

  • Review

MeSH terms

  • Female
  • Humans
  • Immunity, Maternally-Acquired / immunology*
  • Immunogenicity, Vaccine
  • Incidence
  • Infant
  • Meningococcal Infections / immunology
  • Meningococcal Infections / microbiology
  • Meningococcal Infections / prevention & control*
  • Meningococcal Vaccines / immunology
  • Meningococcal Vaccines / therapeutic use*
  • Neisseria meningitidis / genetics
  • Neisseria meningitidis / immunology*
  • Pregnancy
  • Serogroup
  • Vaccination / methods*
  • Vaccines, Conjugate / immunology
  • Vaccines, Conjugate / therapeutic use


  • Meningococcal Vaccines
  • Vaccines, Conjugate